Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats

European Journal of Neuroscience

Volumn 19, Issue 1, 2004, Pages 221-226

  Ozawa, Tohru ^a   Nakagawa, Takayuki ^a   Sekiya, Yumiko ^a   Minami, Masabumi ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Glutamate uptake; Glutamatergic system; Morphine withdrawal; Naloxone

Indexed keywords

GLUTAMATE TRANSPORTER; MORPHINE; NALOXONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE; DRUG INHIBITION; DRUG WITHDRAWAL; ENZYME ASSAY; GENE DELIVERY SYSTEM; GENE TRANSFER; IMPLANTATION; IN VITRO STUDY; IN VIVO STUDY; LOCUS CERULEUS; MALE; NONHUMAN; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TISSUE HOMOGENATE; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; EXCITATORY AMINO ACID TRANSPORTER 2; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLUTAMIC ACID; LOCUS COERULEUS; MORPHINE; MORPHINE DEPENDENCE; NARCOTIC ANTAGONISTS; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT FUSION PROTEINS; SYNAPTIC TRANSMISSION;

EID: 1642458175     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2004.03101.x     Document Type: Article

References (30)

1. Aghajanian, G.K. (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature, 276, 186-188.
2. Aghajanian, G.K., Kogan, J.H. & Moghaddam, B. (1994) Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res., 636, 126-130.
3. Akaoka, H. & Aston-Jones, G. (1991) Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci., 11, 3830-3839.
4. Aston-Jones, G., Ennis, M., Pieribone, V.A., Nickell, W.T. & Shipley, M.T. (1986) The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network. Science, 234, 734-737.
5. Caillé, S., Espejo, E.F., Reneric, J.-P., Cador, M., Koob, G.F. & Stinus, L. (1999) Total neurochemical lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J. Pharmacol. Exp. Ther., 290, 881-892.
6. +-dependent 1-glutamate transport activity in C6 glioma cells by phorbol ester. J. Neurochem., 67, 508-516.
7. Fundytus, M.E. & Coderre, T.J. (1994) Effect of activity at metabotropic, as well as ionotropic (NMDA), glutamate receptors on morphine dependence. Br. J. Pharmacol., 113, 1215-1220.
8. Gonzalez, P., Cabello, P., Germany, A., Norris, B. & Contreras, E. (1997) Decrease of tolerance to, and physical dependence on morphine by, glutamate receptor antagonists. Eur. J. Pharmacol., 332, 257-262.
9. Koob, G.F., Maldonado, R. & Stinus, L. (1992) Neural substrates of opiate withdrawal. Trends Neurosci., 15, 186-191.
10. Le Gal La Salle, G., Robert, J.J., Berrard, S., Ridoux, V., Stratford-Perricaudet, L.D., Perricaudet, M. & Mallet, J. (1993) An adenovirus vector for gene transfer into neurons and glia in the brain. Science, 259, 988-990.
11. Maldonado, R. & Koob, G.F. (1993) Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res., 605, 128-138.
12. Maldonado, R., Stinus, L., Gold, L.H. & Koob, G.F. (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther., 261, 669-677.
13. Mao, J., Sung, B., Ji, R.R. & Lim, G. (2002) Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity. J. Neurosci., 22, 8312-8323.
14. Mennerick, S., Shen, W., Xu, W., Benz, A., Tanaka, K., Shimamoto, K., Isenberg, K.E., Krause, J.E. & Zorumski, C.F. (1999) Substrate turnover by transporters curtails synaptic glutamate transients. J. Neurosci., 19, 9242-9251.
15. Miyake, S., Makimura, M., Nagase, Y., Harada, S., Sato, Y., Takamori, K., Tokuda, C. & Saito, I. (1996) Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl Acad. Sci. USA, 93, 1320-1324.
16. Nakagawa, T., Ozawa, T., Shige, K., Yamamoto, R., Minami, M. & Satoh, M. (2001) Inhibition of morphine tolerance and dependence by MS-153, a glutamate transporter activator. Eur. J. Pharmacol., 419, 39-45.
17. Ozawa, T., Nakagawa, T., Shige, K., Minami, M. & Satoh, M. (2001) Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal. Brain Res., 905, 254-258.
18. Paxinos, G. & Watson, C. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego. CA.
19. Rasmussen, K. (1995) The role of the locus coeruleus and N-methyl-D-aspartic acid (NMDA) and AMPA receptors in opiate withdrawal. Neuropsychopharmacology, 13, 295-300.
20. Rasmussen, K. & Aghajanian, G.K. (1989) Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res., 505, 346-350.
21. Rasmussen, K., Kendrick, W.T., Kogan, J.H. & Aghajanian, G.K. (1996) A selective AMPA antagonist, LY293558, suppresses morphine withdrawal-induced activation of locus coeruleus neurons and behavioral signs of morphine withdrawal. Neuropsychopharmacology, 15, 497-505.
22. Rees, S., Coote, J., Stables, J., Goodson, S., Harris, S. & Lee, M.G. (1996) Bicistronic vector for the creation of stable mammalian cell lines that predisposes all antibiotic-resistant cells to express recombinant protein. Biotechniques, 20, 102-110.
23. Rothstein, J.D., Dykes-Hoberg, M., Pardo, C.A., Bristol, L.A., Jin, L., Kuncl, R.W., Kanai, Y., Hediger, M.A., Wang, Y., Schielke, J.P. & Welty, D.F. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitatory and clearance of glutamate. Neuron, 16, 675-686.
24. Seal, R.P. & Amara, S.G. (1999) Excitatory amino acid transporters: a family in flux. Anna. Rev. Pharmacol ToxicoL, 39, 431-456.
25. Sung, B., Lim, G. & Mao, J. (2003) Altered expression and uptake activity of spinal glutamate transporters after nerve injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci., 23, 2899-2910.
26. Tanaka, K., Watase, K., Manabe, T., Yamada, K., Watanabe, M., Takahashi, K., Iwama, H., Nishikawa, T., Ichihara, N., Kikuchi, T., Okuyama, S., Kawashima, N., Hori, S., Taldmoto, M. & Wada, K. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science, 276, 1699-1702.
27. Tokuyama, S., Zhu, H., Oh, S., Ho, I.K. & Yamamoto, T. (2001) Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids. Neurochem. Int., 39, 103-109.
28. Trujillo, K.A. & Akil, H. (1991) Inhibition of morphine tolerance and dependence by the NMDA receptor antagonist MK-801. Science, 251, 85-87.
29. Watanabe, T., Nakagawa, T., Yamamoto, R., Maeda, A., Minami, M. & Satoh, M. (2002) Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn. J. Pharmacol., 88, 399-406.
30. Zhu, H., Rockhold, R.W. & Ho, I.K. (1998) The role of glutamate in physical dependence on opioids. Jpn. J. Pharmacol., 76, 1-14.